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Abstract: Objectives. To asses the influence of the maternal BMI and glycae-
mic control in women with GDM on the baby's birth weight (BW). 
Material and methods: We analysed 180 women with GDM. Macrosomia has 
been defined as BW > 4000 gm, small for gestational age  < 2700 gm and appropriate for 
gestational age between both. According to the baby´s BW the pregnant women were di-
vided into three groups: group 1 (G1) with BW  < 2700 gm (n = 26); group 2 (G2) with BW 
between 2700 to 4000 gm (n = 117), and group 3 (G3) with BW > 4000 gm (n = 37). 
We also analysed BMI (kg/m²), HbA1c (%), PPG (mmol/L) and time of delivery (WG). 
Results: Comparisons between G1 and G2 showed: BMI (30.7 ± 5 & 31 ± 5.2; 
p < 0.7), HbA1c (6.4 ± 0.8 & 5.1 ± 0.8, p < 0.002), PPG (8.2 ± 1.7 & 6.9 ± 1.5, p < 0.02), 
time of delivery (35.2 ± 3.8 & 38.6 ± 1.5, p < 0.0001) and BW (2289 ± 504 & 3474 ± 334, 
p < 0.0001). Comparisons between G2 and G3 showed: BMI (31 ± 5. 2 & 33.4 ± 6.1; 
p < 0.02), HbA1c (5.2 ± 1.1 & 6.4 ± 2.3, p < 0.02), PPG (6.9 ± 1.5 & 8.2 ± 1.9, p < 0.02), 
time of delivery (38.6 ± 1.5 & 39.3 ± 1.4, p < 0.01) and BW (3474 ± 334 & 4431 ± 302, 
p < 0.0001). Comparisons between G1 and G3 showed the difference at delivery time 
and the baby's BW (p < 0.0001). 
Conclusions: Maternal obesity and PPG contribute to macrosomia and also 
PPG to SGE. 
 
Key words: gestational diabetes, large for gestational age, small for gestational age, 
birth weight, postprandial glycaemia.  
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Introduction 
 
 Approximately 5% of all pregnancies are complicated by gestational 
diabetes mellitus (GDM), which increases both maternal and perinatal morbid-
dity [1]. GDM accounts for 90% of cases of diabetes mellitus in pregnancy [2]. 
GDM is defined as a carbohydrate intolerance that begins or is first diagnosed 
during pregnancy [3]. Maternal supply of carbohydrates leading to foetal hyper-
glycaemia, which in turn stimulates pancreatic islet cells and causes hyperinsu-
linaemia [4]. Stimulation of the insulin-sensitive tissue results in increased foe-
tal growth, predominantly of the abdomen, and delivery of large for gestational 
age (LGA) newborns [5]. Women with large foetuses are at a higher risk of com-
plications of delivery such as infection, caesarean section, pre-eclampsia and 
perinatal mortality [6]. For the infants the risks of immediate complications are 
increased, including intracranial haemorrhage, shoulder dystocia, neonatal hypo-
glycaemia, jaundice, and respiratory distress. The offspring of mothers with GDM 
have high risks of insulin resistance, obesity and type 2 diabetes later in life [7].  
 In treating women with this condition, many have advocated minimi-
zing fluctuations in blood glucose concentrations to avert maternal hyperglycae-
mia and thus decrease the risk of foetal hyperglycemia and its consequences, 
foetal hyperinsulinaemia and excess foetal growth [8]. However, despite early 
diagnosis and aggressive dietary and insulin therapy, perinatal morbidity among 
infants born to women with GDM remains excessive, a fact that may or may not 
be attributed to suboptimal glycaemic control [9]. In the management of GDM, 
various methods of glucose monitoring have been proposed, including the 
measurement of fasting, preprandial, postprandial, and mean 24-hour blood glu-
cose concentrations [1]. Excess nutrient delivery to the foetus causes macroso-
mia, but whether fasting or peak glucose values are more correlated with foetal 
overgrowth is less clear [2].  
 Evidence for an association between maternal HbA1c and the risk of 
foetal macrosomia is conflicting [10]. Evers et al. reported [11] that variations 
in HbA1c levels during pregnancy explained less than 5% of the variation in 
birth weight (BW). 
 Some studies attribute the greater risk of macrosomia to maternal glu-
cose intolerance. Others have reported a stronger relationship between BW and 
maternal pre-pregnancy weight or weight at delivery, than between BW and 
measures of maternal glycaemia. Recently it was shown that maternal glycae-
mia during third trimester and pre-pregnancy body mass index (BMI) are inde-
pendent predictors of BW in pregnancies complicated by GDA, and that obesity 
exerts a significant influence on the risk of delivery of LGA infants [12]. On the 
other hand, in one prospective study of 2,272 women with GDM, only maternal 
BMI predicted neonatal BW, while plasma glucose levels did not [13].  
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 Women who have had GDM have many features of the metabolic syn-
drome and are at very high risk of developing type 2 diabetes. Epidemiological 
observations have suggested a relationship between type 2 diabetes and a low 
BW [13]. Whether glycaemic control in women with GDM predisposes to LGA, 
small for gestational age (SGA), or both, is not clear. 
 The aim of the research was to asses the influence of the maternal BMI 
and glycaemic control in women with GDM on the baby’s BW.  
 
 
Material and methods 
 
 We conducted this cohort study including all consecutive women who 
attended the Outpatient Department of Endocrinology, Diabetes and Metabolic 
disorders in a period from 02.2006 to 02.2009 with singleton pregnancy. The 
diagnosis is established by glucose tolerance testing. 
 According to the guidelines of the ADA [14] we used the 2 steps 
system. A glucose challenge test (GCT) was performed between 24th and 28th 
week of gestation in high and middle risk groups. In GCT, the pregnant women 
underwent a standard 50-g glucose load and a 1-h plasma glucose concentration 
was measured. A plasma glucose ≥ 7.8 mmol/l was considered positive accor-
ding to these recommendations [14]. Those whose initial screening test was ab-
normal went on to complete a diagnostic 3-h 100-g oral glucose tolerance test 
(OGTT). After an overnight fast and at least 3 days of unrestricted diet (≥ 150 g 
carbohydrate per day) and unlimited physical activity, blood was taken to deter-
mine plasma glucose levels. Capillary blood glucose levels were measured by 
glucose oxidase (Glucose Analyzer; Beckman, Brea, CA). The diagnosis was 
made by Carpenter and Coustan’s criteria [15]. Women with GDM were educa-
ted regarding an individualized diabetic diet based on pre-pregnancy weight (30 
kcal · kg−1 · day−1) with caloric restriction for obese women (25 kcal · kg−1 · 
day−1). All women were asked to perform a daily glucose profile (fasting, pre-
prandial and 1-h postprandial measurements) twice a week using a reflectance 
with electronic memory (OneTouch Basic 200–200; LifeScan, Milpitas, Cali-
fornia, USA). Target glucose levels were: fasting glycaemia between 4.0 to 5.5 
mmol/l and 1-hrs postprandial glycaemia > 7.8 mmol/l [16]. Adjustments in the 
insulin doses were made if any of the values were consistently higher than the 
target blood glucose concentrations. 
 Further inclusion criteria were: live birth and no foetal malformation 
suspected during gestation or detected postpartum. All patients gave informed 
consent to participate in the study.  
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 In our research, we investigated the following parameters: patients’ age, 
pre-pregnancy BMI, weight gain during pregnancy, gestational age when GDM 
was diagnosed, arterial blood pressure, fasting and postprandial glycaemia at 
first, second and third trimester, haemoglobin A1c (HbA1c) at first, second and 
third trimester, gestational age at delivery, BW and a baby capillary blood sugar 
level.  
 The BMI of women with GDM was calculated by dividing the weight 
by the height squared (kilograms/metres2). The patients were weighed wearing 
clothes without shoes in the morning with an electronic scale at the first visit. 
Height was measured to the nearest 1 cm with a stadiometer. The gestational 
age was estimated from the date of the last menstrual period. Blood pressure 
was measured twice in a supine position. In a case of hypertension (> 145/90 
mmHg) the measurement was repeated after five minutes. Fasting and postpran-
dial plasma glucose were measured twice a week on alternate weeks from the 
diagnostic moment of GDM until delivery. The blood glucose profiles perfor-
med during the entire pregnancy were averaged to calculate a mean blood glu-
cose level. Blood samples for HbA1c were taken after overnight fasting. HbA1c 
was measured by an ion-exchange HPLC instrument (DS5; Drew, USA) with a 
reference range of 4.2–6%. 
 the baby’s birth weights were classified as LGA, appropriate for gesta-
tional age (AGA) and SGA. LGA we defined as birth weight above 4000 g, 
SGA below 2700g, and AGA between the two. According to the baby’s weight 
the women were further categorized into three groups: group 1 (G1) with BW 
below 2700g, group 2 (G2) with BW between 2700 to 4000g, and group 3 (G3) 
with BW above 4000g.  
 
 
Statistical analysis 
 
 Statistical analysis was performed using the Statistics for Windows pro-
gramme, version 5,0. Dates are given as mean ± standard deviation. We used t-
test for independent samples to compare the variables between each of the 
groups. P < 0.05 was considered statistically significant. 
 
 
Results 
  
 There were 180 women in the total sample. Basic characteristics of the 
patients enrolled into the study are given in Table1. Overall, 20.6% of the preg-
nancies resulted in birth of a LGA baby, while 14% were SGA.  
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Table 1 – Табела 1 
 
Characteristics of the study group 
Каракtерисtики на исpиtуванаtа gруpа 
Variable Valid N Mean Minimum Maximum Std. Dev. 
Age 180 31.55 18 47 5.51 
Gestational age 
at diagnosis  178 27.3 6 40 7.68 
Pre-pregnancy 
BMI (kg/m2) 168 26.89 16 45 5.27 
Weight gain 
(kg/m2) 165 31.45 20 49 5.49 
HbA1c (first 
trimester) % 16 7.113 4.3 11 2.15 
HbA1c (second 
trimester) % 50 5.83 3.85 9.1 0.99 
HbA1c (third 
trimester) %  117 5.87 4.3 10.0 1.07 
SBP (mmHg) 144 120 90 180 15.79 
DBP (mmHg) 144 76 50 120 10.63 
FPG 1 (mmol/l) 13 7.388 3.7 12.5 2.36 
PPG 1 (mmol/l) 13 9.532 5.17 15.4 2.74 
FPG 2 (mmol/l) 64 5.527 3.3 12.9 1.49 
PPG 2 (mmol/l) 65 7.466 4.37 11.5 1.76 
FPG 3 (mmol/l) 167 5.338 3.07 10.75 1.16 
PPG 3 (mmol/l) 166 7.385 2.9 12.7 1.91 
Gestational age 
at delivery 180 38.264 25 42 2.39 
Birth weight (g) 180 3500 700 5410 720.54 
Baby’s glycaemia 
(mmol/l) 89 3.012 0.7 7.4 1.24 
BMI – body mass index, SBP – systolic blood pressure, DBP – diastolic blood pressure, FPG 1, 2, 
3 – fasting plasma glucose value in first, second and third trimester, PPG 1, 2, 3 – postprandial 
glucose value in first, second and third trimester. 
БМИ – индекс на телесна маса, СТА – систолен крвен притисок, ДТА – дијастолен крвен 
притисок, ФПГ 1, 2, 3 – гликемии пред оброк во прв, втор и трет триместар, ППГ 1, 2, 3 – 
гликемии по оброк во прв, втор и трет триместар. 
  
 Comparisons between G1 and G2 [BW (2289 ± 504 and 3474 ± 334, p 
< 0.0001)] showed statistical significant differences between the following pa-
rameters: HbA1c, PPG, and time of delivery (See, Table 2). HbA1c in the se-
cond trimester was higher in women who delivered SGA than in women who 
delivered AGA (6.4 ± 0.8 and 5.1 ± 0.8, p < 0.002). PPG in second (8.2 ± 1.7 
and 6.9 ± 1.5, p < 0.02) and third trimester (8.3 ± 2.2 and 7.3 ± 1.8, p < 0.02) 
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was higher in women who delivered SGA than in women who delivered AGA, 
and time of delivery was shorter in women who delivered SGA than in women 
who delivered AGA (35.2 ± 3.8 and 38.6 ± 1.5, p < 0.0001). Mothers who de-
livered SGA and AGA did not have statistically different values for FPG in any 
trimester.  
 
Table 2 – Табела 2 
 
Comparisons between G1:G2, G2:G3, G1:G3 
Сpоредба pоме|у Г1 и Г2, Г2 и Г3, Г1 и Г3 
Variable Mean 
G1 ± SD 
Mean 
G2 ± SD 
Mean 
G3 ± SD 
p (1 : 2) p (2 : 3) p (1 : 3) 
Age 31.92 ± 5.1 31.55 ± 5.5 31.29 ± 5.6 0.75 0.81 0.65 
Gestational age 
at diagnosis 
24.4 ± 7.1 27.7 ± 7.4 28.1 ± 8.4 0.04 0.78 0.07 
Prepregnancy 
BMI (kg/m2) 
27.5 ± 5.8 26.36 ± 4.8 28.2 ± 6.2 0.31 0.049 0.66 
Weight gain 
(kg/m2) 
30.7 ± 5.02 32 ± 5.3 33.4 ± 6.1 0.79 0.06 0.07 
HbA1c (first 
trimester) % 
7.5 ± 3.3 7.2 ± 2.3 6.7 ± 1.4 0.87 0.68 0.65 
HbA1c (second 
trimester) % 
6,5 ± 0.8 5.5 ± 0 .8 6.1 ± 1.3 0.002 0.08 0.46 
HbA1c (third 
trimester) % 
6,03 ± 0.9 5.7 ± 1.03 6.23 ± 1.2 0.31 0.04 0.54 
SBP (mmHg) 123.9 ± 13.2 117.7 ± 16.7 121.16 ± 14.1 0.1 0.31 0.47 
DBP (mmHg) 79.56 ± 9.2 75.7 ± 10.8 77.3 ± 10.7 0.12 0.48 0.43 
FPG 1 (mmol/l 8.7 ± 3.8 6.8 ± 1.9 7.4 ± 1.7 0.29 0.64 0.6 
PPG 1(mmol/l 12.11 ± 3.03 9.1 ± 2.6 7.9 ± 1.06 0.14 0.48 0.08 
FPG 2(mmol/l 5.6 ± 1.1 5.2 ± 1.2 5.8 ± 2.3 0.35 0.06 0.26 
PPG 2(mmol/l 8.2 ± 1.8 6.99 ± 1.5 8.2 ± 1.9 0.02 0.02 0.99 
FPG 3(mmol/l 5.4 ± 0.6 5.2 ± 1.2 5.6 ± 1.3 0.57 0.13 0.49 
PPG 3(mmol/l 8.3 ± 2.2 7.3 ± 1.8 7.2 ± 1.8 0.02 0.91 0.06 
Gestational age 
at delivery 
35.2 ± 3.8 38.6 ± 1.6 39.3 ± 1.4 0.000 0.01 0.000 
Birth weight (g) 2289 ± 504 3474 ± 334 4431 ± 302 0.000 0.000 0.000 
Baby’s 
glycaemia 
2.8 ± 1.2 3.2 ± 1.3 2.5 ± 0.8 0.34 0.02 0.4 
  
 Comparisons between G2 and G3 [BW (3474 ± 334 and 4431 ± 302, p 
< 0.0001)] showed statistically significant differences between the following 
parameters: pre-pregnancy BMI, HbA1c, PPG, newborn glycaemia, and time of 
delivery (See Table 2). Women who delivered LGA have a higher BMI than 
women with AGA (33.4 ± 6.1and 31 ± 5.2, p < 0.05), HbA1c in third trimester 
is higher in women who delivered LGA than AGA (6.4 ± 2.3 and 5.2 ± 1.1, p < 
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0.02), PPG in second trimester is higher in women who delivered LGA than 
AGA (8.2 ± 1.9 and 6.9 ± 1.5, p < 0.02), LGA newborns had lower glycaemia 
than AGA newborns (2.5 ± 0.8 and 3.2 ± 1.3, p < 0.02), and time of delivery 
was longer in women who delivered LGA, but still in the normal term (39.3 ± 
1.4 and 38.6 ± 1.5, p < 0,01).  
Comparisons between G1 and G3 [BW (2289 ± 504 and 4431 ± 302, p 
< 0.0001)] showed statistically significant differences only between delivery 
time (35.2 ± 3.8 and 39.3 ± 1.4, p < 0.0001) (See Table 2). 
Women with higher BMI are at increased risk of delivering LGA in-
fants. Also women who delivered SGA or LGA had higher HbA1c during the 
second or third trimester, respectively. FPG is not associated with SGA or LGA 
infants, but PPG in the second and third trimester increased the risk of 
delivering an SGA or LGA infant.  
 
 
Discussion 
 
 The results of the study showed that women with higher BMI are at 
increased risk of delivering an LGA infant and PPG contribute to LGA or SGA 
in mothers with GDM. In one study, blood glucose monitoring before meals in 
women with insulin-dependent diabetes mellitus did not provide an adequate 
indication of metabolic control or of the risk of macrosomia; the authors there-
fore recommended postprandial glucose monitoring in order to optimize glycae-
mic control [17]. In another study, macrosomia was related to postprandial but 
not to fasting blood glucose values [18], as in our study. Langer et al. [8] sho-
wed that concentrations of both fasting and postprandial serum glucose were di-
rectly related to BW. We found a more stringent influence of PPG on BW, LGA 
but also on SGA. Jovanovic-Peterson et al. [17] reported that among pre-gesta-
tional diabetic women an increase in the third trimester PPG glucose was a po-
sitive predictor of BW. Our results show that this relationship also exists among 
women diagnosed with GDM. Many of the physicians believed that pre-pran-
dial glucose monitoring was as effective as PPG monitoring [1] but we showed 
that only PPG during treatment has an influence on BW in women with GDM 
developing LGA or SGA infants. 
 Other studies have found that pre-pregnancy BMI and weight gain du-
ring pregnancy are strongly associated with LGA [5, 10, 12, and 13]. In our 
study we found that only pre-pregnancy BMI contributed to LGA. Essentially, 
moderate dietary restriction before conception can decrease BMI and its influ-
ence on BW.  
 Aproximately 15–25% of neonates delivered from women with GDM 
develop hypoglycaemia during the immediate newborn period. Neonatal hypo-
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glycaemia is less frequent when tight glycaemic control is maintained during 
pregnancy [2]. In our study the prevalence of hypoglycaemia was 13.3%. LGA 
newborns had lower glycaemia then AGA newborns, probably because of the 
higher mother glycaemia which contributea to hyperinsulinaemia in the newborn. 
 There were no differences in HbA1c between the groups in the first tri-
mester, but we had a small number of women who enrolled to the study in the 
first trimester. Mothers with SGA and LGA newborns had higher HbA1c than 
mothers with AGA, although mean HbA1c was below 7%, (6.7%, 6.3%, and 
6.1%, respectively). The latter showed good glycaemic control during preg-
nancy in the study group.  
 Time of delivery was significantly different between the three study 
groups. SGA was delivered preterm (mean 35.2 ± 3.8 gestation weeks), which is 
probably responsible for the high percent of SGA (14%) in our study group. 
Surprisingly, LGA were delivered in normal term, but statistically significant 
later than AGA. 
 
 
Conclusion 
 
 Maternal obesity and PPG contribute to macrosomia, and also PPG to 
SGA. Monitoring of PPG levels rather than fasting levels are necessary to pre-
vent SGA and LGA babies.  
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ТЕЖИНА И ГЛИКЕМИСКА КОНТРОЛА НА МАЈКАТА 
ВРЗ РОДИЛНАТА ТЕЖИНА НА БЕБЕТО 
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 Цел: Да се оцени влијанието на индексот на телесна тежина (БМИ) и гли-
кемиската контрола кај мајки со гестациски дијабетес (ГДМ) врз родилната тежи-
на на новороденчињата (РТ).  
 Маtеријали и меtоди: Анализиравме 180 жени со ГДМ. Макросомијата 
беше дефинирана како РТ > 4000 гр, мала телесна тежина за гестациска возраст 
(СГА) < 2700 гр и соодветна за гестациската возраст (АГА) помеѓу двете. Според 
родилната тежина бремените жени беа поделени на три групи: група 1 (Г1) со РТ 
< 2700 гр (n = 26); група 2 (Г2) со РТ од 2700 до 4000 гр (n = 117) и група 3 (Г3) со 
РТ > 4000 гр (n = 37). Анализиравме БМИ, гликолизиран хемоглобин, гликемија 
пред (ФПГ) и по оброк (ППГ) и гестациска недела на породување (ГН). 
 Резулtаtи: Споредбата помеѓу Г1 и Г2 прикажа: БМИ (30,7 ± 5 и 31 ± 5,2; 
p < 0.7), HbA1c (6,4 ± 0.8 & 5,1 ± 0,8, p < 0,002), ППГ (8,2 ± 1,7 & 6,9 ± 1,5, p < 0,02), 
ГН (35,2 ± 3,8 и 38,6 ± 1,5, p < 0.0001) и РТ (2289 ± 504 и 3474 ± 334, p < 0,0001). 
Споредбата помеѓу Г2 и Г3 прикажа: BMI (31 ± 5,2 и 33,4 ± 6,1; p < 0,02), HbA1c 
(5,2 ± 1,1 и 6,4 ± 2,3, p < 0,02), ППГ (6,9 ± 1,5 и 8,2 ± 1,9, p < 0,02), ГН (38,6 ± 1,5 и 
39,3 ± 1,4, p < 0,01) и РТ (3474 ± 334 и 4431 ± 302, p < 0,0001). Споредбата помеѓу 
Г1 и Г3 прикажа разлика во ГН и РТ (p < 0,0001). 
 Заклучок: Обезноста на мајката и ППГ придонесуваaт кон макросомија, а 
исто така и ППГ кон СГА. 
 
Клучни зборови: гестациски дијабетес, голема телесна тежина за гестациска возраст, 
мала телесна тежина за гестациска возраст, родилна тежина, гликемија по оброк. 
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